The DOI matches its Crossref record; 332 of the 332 references it cites were found in a registry or an index.
Global Fluoroquinolone Resistance Epidemiology and Implictions for Clinical Use
Open accessAbstract
This paper on the fluoroquinolone resistance epidemiology stratifies the data according to the different prescription patterns by either primary or tertiary caregivers and by indication. Global surveillance studies demonstrate that fluoroquinolone resistance rates increased in the past years in almost all bacterial species except S. pneumoniae and H. influenzae, causing community-acquired respiratory tract infections. However, 10 to 30% of these isolates harbored first-step mutations conferring low level fluoroquinolone resistance. Fluoroquinolone resistance increased in Enterobacteriaceae causing community acquired or healthcare associated urinary tract infections and intraabdominal infections, exceeding 50% in some parts of the world, particularly in Asia. One to two-thirds of Enterobacteriaceae producing extended spectrum -lactamases were fluoroquinolone resistant too. Furthermore, fluoroquinolones select for methicillin resistance in Staphylococci.Neisseria gonorrhoeae acquired fluoroquinolone resistance rapidly; actual resistance rates are highly variable and can be as high as almost 100%, particularly in Asia, whereas resistance rates in Europe and North America range from <10% in rural areas to >30% in established sexual networks. In general, the continued increase in fluoroquinolone resistance affects patient management and necessitates changes in some guidelines, for example, treatment of urinary tract, intra-abdominal, skin and skin structure infections, and traveller’s diarrhea, or even precludes the use in indications like sexually transmitted diseases and enteric fever.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–332 of 332
Population biology of the human restricted pathogen, Streptococcus pyogenes
Bessen, D. E. (2009) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2009.03.002 · Cited by 115
Endemic and Epidemic Lineages ofEscherichia colithat Cause Urinary Tract Infections
Manges, A. R., Tabor, H., Tellis, P. A., Vincent, C., & Tellier, P. (2008) · Emerging infectious diseases · doi:10.3201/eid1410.080102 · Cited by 115
A Nosocomial Outbreak of Fluoroquinolone‐ResistantStreptococcus pneumoniae
Weiss, K., Restieri, C., Gauthier, R., Laverdière, M., McGeer, A., Davidson, R., Kilburn, L., Bast, D. J., de Azavedo, J., & Low, D. E. (2001) · Clinical Infectious Diseases · doi:10.1086/322658 · Cited by 115
Bisognano, C., Vaudaux, P. E., Lew, D. P., Ng, E. Y., & Hooper, D. C. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.5.906 · Cited by 113
Peirano, G., Richardson, D. C., Nigrin, J., McGeer, A., Loo, V. G., Toye, B., Alfa, M. J., Pienaar, C., Kibsey, P., & Pitout, J. D. D. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01338-09 · Cited by 113
Pletz, M. W., McGee, L., Jorgensen, J. H., Beall, B., Facklam, R. R., Whitney, C. G., & Klugman, K. P. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.9.3491-3497.2004 · Cited by 112
Resistance surveillance studies: a multifaceted problem—the fluoroquinolone example
Dalhoff, A. (2012) · Infection · doi:10.1007/s15010-012-0257-2 · Cited by 111
Self-citationFluoroquinolone‐ResistantStreptococcus pneumoniaeAssociated with Levofloxacin Therapy
Urban, C. M., Rahman, N. A., Zhao, X., Mariano, N., Segal‐Maurer, S., Drlica, K., & Rahal, J. J. (2001) · The Journal of Infectious Diseases · doi:10.1086/323086 · Cited by 110
The SOS response promotes qnrB quinolone‐resistance determinant expression
Re, S. D., Garnier, F., Guérin, É., Campoy, S., Denis, F., & Ploy, M. C. (2009) · EMBO Reports · doi:10.1038/embor.2009.99 · Cited by 107
Is plasmid-mediated quinolone resistance a clinically significant problem?
Poirel, L., Cattoir, V., & Nordmann, P. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01930.x · Cited by 103
Plachouras, D., Kavatha, D., Antoniadou, A., Giannitsioti, E., Poulakou, G., Kanellakopoulou, K., & Giamarellou, H. (2010) · Eurosurveillance · doi:10.2807/ese.15.07.19488-en · Cited by 103
Burns, J. L., Saiman, L. M., Whittier, S., Larone, D. H., Krzewinski, J., Liu, Z., Marshall, S. A., & Jones, R. N. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.5.1818-1822.2000 · Cited by 98
Role of a qnr -Like Gene in the Intrinsic Resistance of Enterococcus faecalis to Fluoroquinolones
Arsene, S., & Leclercq, R. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00274-07 · Cited by 98
Chen, Y., Hsueh, P., Badal, R. E., Hawser, S., Hoban, D. J., Bouchillon, S. K., Ni, Y., & Paterson, D. L. (2011) · Journal of Infection · doi:10.1016/j.jinf.2011.02.009 · Cited by 95
The Alexander Project: the benefits from a decade of surveillance
Felmingham, D., White, A. R., Jacobs, M. R., Appelbaum, P. C., Poupard, J. A., Miller, L. A., & Grüneberg, R. N. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki297 · Cited by 94
Kays, M. B., Smith, D. W., Wack, M. F., & Denys, G. A. (2002) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.22.5.395.33185 · Cited by 93
Cantón, R., Loza, E., Morosini, M. I., & Baquero, F. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf811 · Cited by 92
Tam, V. H., Louie, A., Fritsche, T. R., Deziel, M. R., Liu, W., Brown, D. L., Deshpande, L. M., Leary, R. H., Jones, R. N., & Drusano, G. L. (2007) · The Journal of Infectious Diseases · doi:10.1086/518003 · Cited by 92
Koeth, L. M., Good, C. E., Appelbaum, P. C., Goldstein, E. J. C., Rodloff, A. C., Claros, M., & Dubreuil, L. J. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh248 · Cited by 91
Ciprofloxacin for eradication of methicillin-resistant Staphylococcus aureus colonization.
Mulligan, M. E., Ruane, P. J., Johnston, L., Wong, P., Wheelock, J. P., Macdonald, K. E., Reinhardt, J. F., Johnson, C. C., Statner, B., & Blomquist, I. K. (1987) · PubMed · Cited by 90
Jones, R. N., Mendes, R. E., & Sader, H. S. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq252 · Cited by 90
Apisarnthanarak, A., Kiratisin, P., Saifon, P., Kitphati, R., Dejsirilert, S., & Mundy, L. M. (2007) · American Journal of Infection Control · doi:10.1016/j.ajic.2007.05.008 · Cited by 89
Increased Antibiotic Resistance in Respiratory Tract Pathogens: PROTEKT US—An Update
Karchmer, A. W. (2004) · Clinical Infectious Diseases · doi:10.1086/421352 · Cited by 89
The Importance and Future of Antimicrobial Surveillance Studies
Masterton, R. G. (2008) · Clinical Infectious Diseases · doi:10.1086/590063 · Cited by 88
Community-acquired methicillin-resistant Staphylococcus aureus: what do we need to know?
Witte, W. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.03097.x · Cited by 87
Mandomando, I., Jaintilal, D., Pons, M. J., Vallès, X., Espasa, M., Mensa, L., Sigaúque, B., Sanz, S., Sacarlal, J., Macete, E., et al. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01282-08 · Cited by 87
Quinolone resistance in Escherichia coli from Accra, Ghana
Namboodiri, S. S., Opintan, J. A., Lijek, R. S., Newman, M. J., & Okeke, I. N. (2011) · BMC Microbiology · doi:10.1186/1471-2180-11-44 · Cited by 87
Brown, S. D. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh313 · Cited by 82
Goldman, J. D., White, D. G., & Levy, S. B. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.5.1266 · Cited by 80
Hawser, S., Bouchillon, S. K., Hoban, D. J., Badal, R. E., Cantón, R., & Baquero, F. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00265-10 · Cited by 79
Bébéar, C., de Barbeyrac, B., Pereyre, S., Renaudin, H., Clerc, M., & Bébéar, C. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.02027.x · Cited by 77
Shim, B. S., Kim, C. S., Kim, M. E., Lee, S.-J., Lee, D. S., Choe, H., & Cho, Y. H. (2010) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-010-0178-x · Cited by 77
Association of Plasmid-Mediated Quinolone Resistance with Extended-Spectrum β-Lactamase VEB-1
Poirel, L., Loo, M. V. D., Mammeri, H., & Nordmann, P. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.7.3091-3094.2005 · Cited by 77
Nationale S3-Leitlinie „Unkomplizierte Harnwegsinfektionen“
Wagenlehner, F., Schmiemann, G., Hoyme, U. B., Fünfstück, R., Hummers, E., Kaase, M., Kniehl, E., Selbach, I., Sester, U., Vahlensieck, W., et al. (2011) · Der Urologe · doi:10.1007/s00120-011-2512-z · Cited by 77
Shiferaw, B., Solghan, S. M., Palmer, A., Joyce, K. W., Barzilay, E. J., Krueger, A. L., & Cieslak, P. R. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis230 · Cited by 75
Gobernado, M., Valdés, L., Alós, J.-I., García-Rey, C., Dal−Ré, R., & García-de-Lomas, J. (2007) · PubMed · Cited by 75
Fluoroquinolone Resistance in Penicillin-resistantStreptococcus pneumoniaeClones, Spain
de la Campa, A. G., Balsalobre, L., Ardanuy, C., Fenoll, A., Pérez‐Trallero, E., Liñares, J., & the Spanish Pneumococcal Infection Study Network G03/103 (2004) · Emerging infectious diseases · doi:10.3201/eid1010.040382 · Cited by 74
Quinolone Resistance Due to Reduced Target Enzyme Expression
İnce, D., & Hooper, D. C. (2003) · Journal of Bacteriology · doi:10.1128/jb.185.23.6883-6892.2003 · Cited by 74
Ouyang‐Latimer, J., Jafri, S. H. R., VanTassel, A., Jiang, Z., Gurleen, K., Rodriguez, S., Nandy, R. K., Ramamurthy, T., Chatterjee, S., McKenzie, R., et al. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00739-10 · Cited by 73
Sahm, D. F., Peterson, D. E., Critchley, I. A., & Thornsberry, C. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.9.2521-2524.2000 · Cited by 73
Critchley, I. A., Brown, S. D., Traczewski, M. M., Tillotson, G. S., & Janjić, N. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00971-07 · Cited by 72
High rates of quinolone resistance among urinary tract infections in the ED
Khawcharoenporn, T., Vasoo, S. S., Ward, E., & Singh, K. S. (2010) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2010.09.030 · Cited by 71
Norfloxacin binds to human fecal material
Edlund, C., LINDQVIST, L., & Nord, C. E. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.12.1869 · Cited by 71
Sm qnr , a New Chromosome-Carried Quinolone Resistance Gene in Stenotrophomonas maltophilia
Shimizu, K., Kikuchi, K., Sasaki, T., Takahashi, N., Ohtsuka, M., Ono, Y., & Hiramatsu, K. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00026-08 · Cited by 71
Schülin, T. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/49.2.403 · Cited by 70
Goldstein, E. J. C., Citron, D. M., Warren, Y. A., Tyrrell, K. L., Merriam, C. V., & Fernandez, H. T. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.1.148-155.2006 · Cited by 69
Antimicrobial resistance in major pathogens of hospital-acquired pneumonia in Asian countries
Lagamayo, E. N. (2008) · American Journal of Infection Control · doi:10.1016/j.ajic.2007.10.020 · Cited by 68
Kalter, H. D., Gilman, R. H., Moulton, L. H., Cullotta, A. R., Cabrera, L. Z., & Velapatiño, B. (2010) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2010.09-0143 · Cited by 67
SOS Regulation of qnrB Expression
Wang, M., Jacoby, G. A., Mills, D. M., & Hooper, D. C. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00132-08 · Cited by 67
Qnr-like pentapeptide repeat proteins in Gram-positive bacteria
Rodríguez-Martínez, J. M., Velasco, C., Briales, A., García, I., Conejo, M. C., & Pascual, Á. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn115 · Cited by 67
Llor, C., Rabanaque, G., López, A., & Cots, J. M. (2010) · Family Practice · doi:10.1093/fampra/cmq107 · Cited by 65
Evolutionary Barriers to Quinolone Resistance in Streptococcus pneumoniae
Gillespie, S. H., Voelker, L. L., & Dickens, A. L. (2002) · Microbial Drug Resistance · doi:10.1089/107662902760190617 · Cited by 64
Vilà, J., Vargas, M., Ruiz, J., Corachan, M., de Anta, M. T. J., & Gascón, J. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.6.1731-1733.2000 · Cited by 64
Ciprofloxacin-Resistant Gram-Negative Bacilli in the Fecal Microflora of Children
Qin, X. G., Razia, Y., Johnson, J. R., Stapp, J. R., Boster, D. R., Tsosie, T., Smith, D. L., Braden, C. R., Gay, K., Angulo, F. J., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00548-06 · Cited by 64
The role of the SOS response in bacteria exposed to zidovudine or trimethoprim
Lewin, C. S., & Amyes, S. G. B. (1991) · Journal of Medical Microbiology · doi:10.1099/00222615-34-6-329 · Cited by 62
Efflux Pumps and Nosocomial Antibiotic Resistance: A Primer for Hospital Epidemiologists
Weinstein, R. A., & Hooper, D. C. (2005) · Clinical Infectious Diseases · doi:10.1086/430381 · Cited by 62
den Heijer, C. D. J., Donker, G., Maes, J.-M., & Stobberingh, E. E. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq286 · Cited by 61
Wajima, T., Murayama, S. Y., Sunaoshi, K., Nakayama, E., Sunakawa, K., & Ubukata, K. (2008) · Journal of Medical Microbiology · doi:10.1099/jmm.0.2008/002642-0 · Cited by 61
Kim, M. E., Ha, U., & Cho, Y. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.07.043 · Cited by 58
Lee, D. S., Lee, C. B., & Lee, S.-J. (2010) · Korean journal of urology · doi:10.4111/kju.2010.51.7.492 · Cited by 58
Dhanji, H., Doumith, M., Rooney, P. J., O'Leary, M. C., Loughrey, A. C., Hope, R., Woodford, N., & Livermore, D. M. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq463 · Cited by 57
Hospital and community isolates of uropathogens at a tertiary hospital in South Africa.
Habte, T. M., Dube, S., Ismail, N. A., & Hoosen, A. A. (2009) · PubMed · Cited by 57
Ho, P., Yip, K.-S., Chow, K., Lo, J. Y. C., Que, T., & Yuen, K. (2009) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2009.03.027 · Cited by 56
Antimicrobial susceptibility of community-acquired uropathogens in northern Israel
Colodner, R., Keness, Y., Chazan, B., & Raz, R. (2001) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(01)00368-5 · Cited by 55
Hawser, S., Bouchillon, S. K., Lascols, C., Hackel, M., Hoban, D. J., Badal, R. E., & Cantón, R. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03550.x · Cited by 53
Yokota, S., Ohkoshi, Y., Sato, K., & Fujii, N. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.01561-07 · Cited by 53
Fluoroquinolone-Resistant Typhoid, South Africa
Keddy, K. H., Smith, A. M., Sooka, A., Ismail, H., & Oliver, S. (2010) · Emerging infectious diseases · doi:10.3201/eid1605.091917 · Cited by 52
Pournaras, S., Ikonomidis, A., Markogiannakis, A., Spanakis, N., Maniatis, A. N., & Tsakris, A. (2006) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46816-0 · Cited by 51
Skin and skin structure infections: treatment with newer generation fluoroquinolones
Giordano, P., Weber, K. D., Gesin, G., & Kubert, J. (2007) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.2007.3.2.309 · Cited by 49
ISON, C. A., Woodford, P. J., Madders, H., & Claydon, E. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.11.2919 · Cited by 49
Quinolone and cephalosporin resistance in enteric fever
Capoor, M. R., & Nair, D. (2010) · Journal of Global Infectious Diseases · doi:10.4103/0974-777x.68529 · Cited by 48
Neuzillet, Y., Naber, K. G., Schito, G. C., Gualco, L., & Botto, H. (2012) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2011.07.005 · Cited by 48
Antibiotic resistance patterns of intestinal Escherichia coli isolates from Nicaraguan children
Amaya, E., Reyes, D., Vilchez, S., Paniagua, M., Möllby, R., Nord, C. E., & Weintraub, A. (2010) · Journal of Medical Microbiology · doi:10.1099/jmm.0.020842-0 · Cited by 47
Yang, Q., Wang, H., Chen, M., Ni, Y., Yu, Y., Hu, B., Sun, Z., Huang, W., Hu, Y., Ye, H., et al. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2010.09.001 · Cited by 46
Update in Community-acquired and Nosocomial Pneumonia 2009
Torres, A., & Rello, J. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201001-0030up · Cited by 46
Biedenbach, D. J., & Jones, R. N. (2003) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(03)00016-6 · Cited by 45
Johnson, J. R., Anderson, J. T., Clabots, C., Johnston, B., & Cooperstock, M. S. (2010) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181c89bd7 · Cited by 44
Antimicrobial use and Pseudomonas aeruginosa susceptibility profile in a cystic fibrosis centre
Manno, G., Cruciani, M., Romano, L., Scapolan, S., Mentasti, M., Lorini, R., & Minicucci, L. (2005) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2004.11.009 · Cited by 43
Sahm, D. F. (2008) · Postgraduate Medicine · doi:10.3810/pgm.2008.09.suppl52.279 · Cited by 43
Mendes, R. E., Sader, H. S., Deshpande, L. M., Diep, B. A., Chambers, H. F. “., & Jones, R. N. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.01384-09 · Cited by 43
Mehta, S. D., Maclean, I., Ndinya‐Achola, J. O., Moses, S., Martín, I., Ronald, A., Agunda, L., Murugu, R., Bailey, R. C., Melendez, J. H., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00155-11 · Cited by 43
Lau, J. T. F., Kim, J. H., & Tsui, H. Y. (2005) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3901368 · Cited by 42
Vellinga, A., Murphy, A. W., Hanahoe, B., Bennett, K., & Cormican, M. T. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq149 · Cited by 42
Yagci, D., Yörük, F., Azap, A., & Memikoğlu, O. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01228-08 · Cited by 42
de Vries, H. J. C., van der Helm, J. J., van der Loeff, M. F. S., & van Dam, A. P. (2009) · Eurosurveillance · doi:10.2807/ese.14.37.19330-en · Cited by 41
Morrissey, I., Maher, K., Williams, L., et al. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn356 · Cited by 41
Lascols, C., Podglajen, I., Verdet, C., Gautier, V., Gutmann, L., Soussy, C., Collatz, E., & Cambau, E. (2008) · Journal of Bacteriology · doi:10.1128/jb.00243-08 · Cited by 41
Current concepts in managing pelvic inflammatory disease
Judlin, P. (2009) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e328334de21 · Cited by 40
Yamaguchi, K., & Ohno, A. (2005) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2005.02.009 · Cited by 39
Clonal spread of fluoroquinolone non-susceptible Streptococcus pyogenes
Malhotra‐Kumar, S., Lammens, C., Chapelle, S., Mallentjer, C., Weyler, J., & Goossens, H. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki011 · Cited by 39
Jones, M. E., Blosser-Middleton, R. S., Thornsberry, C., Karlowsky, J. A., & Sahm, D. F. (2003) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(03)00140-8 · Cited by 39
García-Rey, C., Aguilar, L., Baquero, F., & Spanish Surveillance Group for Respiratory Pathogens (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.12.3481-3482.2000 · Cited by 38
Ikebe, T., Hirasawa, K., Suzuki, R., Isobe, J., Tanaka, D., Katsukawa, C., Kawahara, R., Tomita, M., Ogata, K., Endoh, M., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.788-790.2005 · Cited by 38
Ciprofloxacin-resistant campylobacteriosis in the UK
Cody, A. J., Clarke, L. A., Bowler, I. C. J. W., & Dingle, K. E. (2010) · The Lancet · doi:10.1016/s0140-6736(10)62261-1 · Cited by 37
Nicoletti, J., Kuster, S. P., Sulser, T., & Ledergerber, B. (2010) · Swiss Medical Weekly · doi:10.4414/smw.2010.13059 · Cited by 37
Klinik und Epidemiologie der unkomplizierten Zystitis bei Frauen
Wagenlehner, F. R. A., Wagenlehner, C. M., Savov, O., Gualco, L., Schito, G. C., & Naber, K. G. (2009) · Der Urologe · doi:10.1007/s00120-009-2145-7 · Cited by 36
Pletz, M. W., van der Linden, M., von Baum, H., Duesberg, C., Klugman, K. P., & Welte, T. (2010) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2010.05.004 · Cited by 36
CTX-M-15–producing Enteroaggregative Escherichia coli as Cause of Travelers' Diarrhea
Guiral, E., Méndez-Arancibia, E., Soto, S. M., Salvador, P., Fàbrega, A., Gascón, J., & Vilà, J. (2011) · Emerging infectious diseases · doi:10.3201/eid1710.110022 · Cited by 36
Fluoroquinolone Resistance inStreptococcus pyogenes
Richter, S. S., Diekema, D. J., Heilmann, K. P., Almer, L. S., Shortridge, V. D., Zeitler, R., Flamm, R. K., & Doern, G. V. (2003) · Clinical Infectious Diseases · doi:10.1086/345904 · Cited by 36
Rational parameters for antibiotic therapy in patients with cystic fibrosis
Govan, J. R. W., Doherty, C. J., & Glass, S. (1987) · Infection · doi:10.1007/bf01644142 · Cited by 35
ISON, C. A. (2011) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e32834e9a6a · Cited by 35
Beilman, G. J., Sandifer, G., Skarda, D. E., Jensen, B. J., McAllister, S. K., Killgore, G., & Srinivasan, A. (2005) · Surgical Infections · doi:10.1089/sur.2005.6.87 · Cited by 34
Jacobs, E., Dalhoff, A., & Korfmann, G. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.07.017 · Cited by 33
Self-citationEuropean guideline for the management of chancroid, 2011
Kemp, M., Christensen, J. J., Lautenschlager, S., Vall-Mayans, M., & Moi, H. (2011) · International Journal of STD & AIDS · doi:10.1258/ijsa.2010.010432 · Cited by 32
Multidrug-resistant Neisseria gonorrhoeae
(2009) · doi:10.1503/cmaj.081721 · Cited by 32
DiPersio, J. R., Jones, R. N., Barrett, T. J., Doern, G. V., & Pfaller, M. A. (1998) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(98)00083-2 · Cited by 31
Population dynamics of Neisseria gonorrhoeae in Shanghai, China: a comparative study
Tazi, L., Pérez‐Losada, M., Gu, W., et al. (2010) · BMC Infectious Diseases · doi:10.1186/1471-2334-10-13 · Cited by 31
Pottumarthy, S., Fritsche, T. R., Sader, H. S., Stilwell, M. G., & Jones, R. N. (2005) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2004.12.001 · Cited by 31
Risk Factors for Fecal Quinolone-Resistant Escherichia coli in Mexican Children
Zaidi, M. B., Zamora, E., Diaz-Rengifo, P. E., Tollefson, L., Fedorka–Cray, P. J., & Headrick, M. L. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.6.1999-2001.2003 · Cited by 31
Antimicrobial Resistance of Urinary Escherichia coli Isolates
Eryılmaz, M., Bozkurt, M., Yildiz, M., & Akin, A. (2010) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v9i2.53712 · Cited by 30
Activity In Vitro of the Quinolones
Thauvin-Eliopoulos, C., & Eliopoulos, G. M. (2014) · ASM Press eBooks · doi:10.1128/9781555817817.ch5 · Cited by 29
Smaqnr, a new chromosome-encoded quinolone resistance determinant in Serratia marcescens
Velasco, C., Rodríguez-Martínez, J. M., Briales, A., de Alba, P. D., Calvo, J., & Pascual, Á. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp424 · Cited by 29
Pletz, M. W., Shergill, A. P., McGee, L., Beall, B., Whitney, C. G., & Klugman, K. P. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1561-1563.2006 · Cited by 29
Françoise Van Bambeke, A., Pagès, J., & LEE, V. J. (2010) · Cited by 27
Longhi, C., Conte, M. P., Marazzato, M., Iebba, V., Totino, V., Santangelo, F., Gallinelli, C., Pallecchi, L., Riccobono, E., Schippa, S., et al. (2011) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-011-1521-6 · Cited by 24
Shopsin, B., Zhao, X., Kreiswirth, B. N., Tillotson, G., & Drlica, K. (2004) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2004.03.009 · Cited by 24
Risk factors of ciprofloxacin resistance in urinary Escherichia coli isolates.
Lin, C., Huang, S., Chen, T., Lu, P., Lin, W., & Chen, Y. (2008) · PubMed · Cited by 23
Heirstraeten, L. V., Leten, G., Lammens, C., Goossens, H., & Malhotra‐Kumar, S. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks281 · Cited by 23
Antimicrobial resistance in uncomplicated urinary tract infections in 3 California EDs
Moffett, S. E., Frazee, B. W., Stein, J. C., Navab, B., Maselli, J. H., Takhar, S. S., & Gonzales, R. (2011) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2011.05.008 · Cited by 21
Lagacé-Wiens, P. R. S., Nichol, K. A., Nicolle, L. E., DeCorby, M. R., McCracken, M., Alfa, M. J., Mulvey, M. R., & Zhanel, G. G. (2006) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2007/848194 · Cited by 19
Morosini, M.-I., Loza, E., del Campo, R., Almaraz, F., Baquero, F., & Cantón, R. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.8.2692-2695.2003 · Cited by 19
New approaches to combating antimicrobial drug resistance.
Avison, M. B. (2005) · Genome biology · doi:10.1186/gb-2005-6-13-243 · Cited by 18
Morris, S., Knapp, J. S., Moore, D. F., et al. (2008) · Sexually Transmitted Infections · doi:10.1136/sti.2008.030163 · Cited by 18
Antibiotic Use: The Crystal Ball for Predicting Antibiotic Resistance
Pantosti, A., & Moro, M. L. (2005) · Clinical Infectious Diseases · doi:10.1086/429248 · Cited by 16
Morris, S., Moore, D. F., Hannah, P., et al. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.01001-09 · Cited by 16
Pérez‐Losada, M., Crandall, K. A., Bash, M. C., Dan, M., Zenilman, J. M., & Viscidi, R. P. (2007) · BMC Evolutionary Biology · doi:10.1186/1471-2148-7-84 · Cited by 14
Lee, S. Y., Fan, H. W., Sutherland, C. A., DeRyke, C. A., & Nicolau, D. P. (2007) · Drugs in R&D · doi:10.2165/00126839-200708020-00001 · Cited by 13
Antimicrobial resistance among invasive isolates of Streptococcus pneumoniae collected across Canada
Davidson, R., Melano, R. G., & Forward, K. R. (2007) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2007.03.024 · Cited by 12
Bala, M. (2011) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e31822e6361 · Cited by 11
Risk Factors for Quinolone-Resistant Escherichia coli Urinary Tract Infection
Vasquez, G. A., Siu, H. R., Luna, E. M., Reyes, K. C., & Zervos, M. (2009) · Infectious Diseases in Clinical Practice · doi:10.1097/ipc.0b013e3181a4c728 · Cited by 10
Quinolone Resistance and Its Clinical Relevance
Low, D. E. (2014) · ASM Press eBooks · doi:10.1128/9781555817817.ch23 · Cited by 8
Fluoroquinolone resistance in Streptococcus pneumoniae from a university hospital, Thailand.
Srifuengfung, S., Tribuddharat, C., Chokephaibulkit, K., & Comerungsee, S. (2010) · PubMed · Cited by 3
Cited by
Systematic Review of Complications of Prostate Biopsy
Loeb, S., Vellekoop, A., Ahmed, H. U., Catto, J., Emberton, M., Nam, R., Rosario, D. J., Scattoni, V., & Lotan, Y. (2013) · European Urology · doi:10.1016/j.eururo.2013.05.049 · Cited by 1,073
Drugging Topoisomerases: Lessons and Challenges
Pommier, Y. (2013) · ACS Chemical Biology · doi:10.1021/cb300648v · Cited by 839
Horizontal transfer of antibiotic resistance genes in clinical environments
Lerminiaux, N. A., & Cameron, A. D. S. (2019) · Canadian Journal of Microbiology · doi:10.1139/cjm-2018-0275 · Cited by 802
Pham, T. D. M., Ziora, Z. M., & Blaskovich, M. A. T. (2019) · MedChemComm · doi:10.1039/c9md00120d · Cited by 785
The Surgical Infection Society Revised Guidelines on the Management of Intra-Abdominal Infection
Mazuski, J. E., Tessier, J. M., May, A. K., Sawyer, R. G., Nadler, E. P., Rosengart, M. R., Chang, P. K., O'Neill, P. J., Mollen, K. P., Huston, J. M., et al. (2017) · Surgical Infections · doi:10.1089/sur.2016.261 · Cited by 573
Metadata
- Authors
- Dalhoff, A.
- Venue
- Interdisciplinary Perspectives on Infectious Diseases
- Publisher
- Wiley
- Published
- 2012
- Volume
- 2012
- Pages
- 1-37
- ISSN
- 1687-708X (ISSN-L)
- 1687-7098
- OpenAlex
- W2046548856
- Cited by
- 354
- References
- 332
- FWCI
- 7.04
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.